Loading...
01/10 16:01
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals mixed signals: revenue and EPS declined year-over-year, indicating potential challenges. However, the company maintains strong cash flow and plans for share repurchases, which are positive. The Q&A section highlights some uncertainties, particularly around costs and guidance. The acquisition of blue-chip customers offers growth potential, but management's vague responses on key areas like online channels and future margins suggest caution. Overall, the sentiment is neutral, with no strong catalysts for significant stock price movement.
Fourth Quarter Revenue $X million, down 1% year-over-year due to a strong prior year quarter, with positive growth in healthcare, apparel, and contact centers offset by a decrease in branded products.
Fourth Quarter EPS $0.13, down from $0.22 year-over-year, attributed to a tough comparison with the outsized strength in Q4 2023.
Fourth Quarter Gross Margin 37.1%, down 70 basis points year-over-year, despite tough comparisons.
Fourth Quarter EBITDA $7.3 million, down from $9.9 million year-over-year.
Branded Products Revenue Down 5% year-over-year, primarily due to lower sales of branded uniforms with existing customers.
Healthcare Revenue Up 8% year-over-year, driven by growth in digital channels and favorable sales timing.
Contact Centers Revenue Up 4% year-over-year, with new customers offsetting declines from existing customers.
Branded Products Gross Margin 33.9%, down 1 percentage point year-over-year, driven by sourcing mix and lower volume.
Healthcare Apparel Gross Margin 33.7%, down 3 percentage points year-over-year due to higher sourcing costs.
Contact Centers Gross Margin 54.7%, up more than 2.5 percentage points year-over-year.
Fourth Quarter Interest Expense $1.5 million, improved from $2.1 million year-over-year due to lower debt and interest rates.
Fourth Quarter Net Income $2.1 million, down from $3.6 million year-over-year.
Year-End Cash and Cash Equivalents $19 million, down from $20 million year-over-year, despite share repurchases and a small acquisition.
Outstanding Debt $86 million at year-end, improved from $93 million year-over-year.
Operating Cash Flow for the Year $33 million, supporting a net leverage ratio of 1.7 times trailing twelve months EBITDA, improved from 2 times at the start of the year.
Share Repurchases in Q4 Approximately 72,000 shares for $1.1 million at an average price of $14.96 per share.
New Products: Achieved modest growth in the promotional products channel driven by a combination of both new and existing customers.
Healthcare Apparel: Investing in sales, branding, and marketing to drive brand awareness and grow digital channels.
Contact Centers: Revenue growth potential with a newly established sales team and implementation of latest technology to enhance customer experience.
Market Expansion: Looking to grow digital channels in healthcare apparel, both wholesale and direct to consumer.
Customer Base Expansion: Investing in sales leadership to expand share of wallet with existing customers and add new customers.
Operational Efficiencies: Focusing on cost management and maximizing operational efficiencies.
Sales Strategy: Implementing latest technology to optimize costs and long-term profitability.
Strategic Investments: Maintaining a strong leverage ratio to make strategic investments in attractive end markets.
Share Repurchase Program: Announced an additional $17.5 million share repurchase plan with no expiration.
Earnings Expectations: The company missed earnings expectations with reported EPS of $0.13 compared to expectations of $0.22.
Market Conditions: Current macroeconomic conditions present numerous challenges, including customer hesitancy, geopolitical conflicts, and the new administration's impact on economic direction.
Revenue Decline: Consolidated revenue was down 1% year-over-year, with a notable decline in the branded product segment.
Healthcare Apparel Challenges: Healthcare apparel market conditions remain soft, particularly in brick-and-mortar wholesale channels.
Sourcing Costs: Higher sourcing costs related to manufacturing in Haiti negatively impacted gross margins in the healthcare apparel segment.
Customer Hesitancy: Lingering factors resulting in customer hesitancy and overall economic uncertainty are expected to affect future performance.
Debt Levels: Despite a reduction in outstanding debt to $86 million, the company remains cautious about economic factors influencing financial stability.
Operational Efficiency: The company is focusing on cost management and operational efficiencies to navigate economic challenges.
Strategic Investments: The company is committed to making strategic investments in three attractive end markets while also opportunistically repurchasing shares.
Sales Leadership Investment: Investing in sales leadership to expand share of wallet with existing customers and to add new customers at a faster pace.
Healthcare Apparel Growth: Investing in sales, branding, and marketing to drive brand awareness in healthcare apparel.
Contact Center Strategy: Implementing latest technology to enhance customer experience and optimize costs for long-term profitability.
2025 Revenue Guidance: Full-year revenues expected to be in the range of $585 million to $595 million, suggesting year-over-year growth at the high end of 5%.
2025 EPS Guidance: Full-year earnings per diluted share expected to be in the range of $0.75 to $0.82, suggesting 12% year-over-year growth at the high end.
2025 Performance Cadence: Expecting a back-end weighted cadence to 2025 similar to the past two years.
Share Repurchase Program: During the fourth quarter, approximately 72,000 shares were repurchased for $1.1 million at an average price of $14.96 per share. An additional $17.5 million share repurchase plan has been authorized with no expiration.
The earnings report shows mixed results: a decline in revenue and margins, but cost savings and a strong Branded Products pipeline. Despite negative trends in the Contact Center and declining EBITDA, optimistic guidance for revenue growth in Q4 and potential acquisitions provide balance. The Q&A highlights challenges in client retention and tariff impacts, but also potential revenue normalization. Without market cap data, the net effect suggests a neutral stock movement, as the positive and negative factors seem to offset each other.
The earnings call reflects strong financial performance with increased net income and decreased net interest expense. Product development shows potential with AI integration, and market strategy is optimistic despite some uncertainties. Management's reiteration of revenue guidance and successful tariff mitigation efforts are positive indicators. Shareholder return plans are not explicitly mentioned, but overall, the sentiment is positive with a focus on growth and cost efficiency.
The earnings call reveals mixed signals: revenue and EPS declined year-over-year, indicating potential challenges. However, the company maintains strong cash flow and plans for share repurchases, which are positive. The Q&A section highlights some uncertainties, particularly around costs and guidance. The acquisition of blue-chip customers offers growth potential, but management's vague responses on key areas like online channels and future margins suggest caution. Overall, the sentiment is neutral, with no strong catalysts for significant stock price movement.
The earnings call revealed mixed signals: revenue growth and share repurchase are positive, but declining EPS, margins, and unclear guidance are concerns. The Q&A highlighted cost pressures and management's evasive responses, further clouding the outlook. The absence of market cap data limits impact assessment, but the overall sentiment is neutral due to offsetting positive and negative factors.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
